Ripertamab

Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).
Read more
€0.00 (tax incl.)
Reference:
HY-P99952
Product Details
HY-P99952

Data sheet

Size
Multiple sizes
Reactivity
CD20
CAS
2249927-04-4

Menu

Settings